The European Patent Office (EPO) has announced a pilot project to trial opposition hearings by video conference, which will run until 30 April 2021.
The World Health Organisation has now called for a broader sharing of knowledge, data and intellectual property in their Solidarity Call to Action, stating that "the single most important priority of the global community is to stop the COVID-19 pandemic in its tracks"
The recent Board of Appeal decision T1385/15 concerns European patent EP1865998, which claimed a disinfectant agent for killing bacterial, viruses and fungi through mechanical disinfection of a surface.
In an unsurprising but nevertheless disappointing move, the UK has unequivocally stated that they will not be part of the UPC, despite having ratified its agreement in April 2018.
Updated 25 June: Latest updates from the intellectual property offices of the UK, and Europe, and details of relief available to clients affected by Covid-19.
In view of the spread of Covid-19 (coronavirus) and everchanging responses by the UK and Europe, we are monitoring the situation closely and will report any changes that affect our operations or those of the UK and European intellectual property offices.
A party may not be able to accelerate appeal proceedings at the EPO if they initiate the proceedings in the name of another party in order to conceal their identity.
In case T 1299/15 the Boards of Appeal reasoned the burden of proof had shifted from the opponent to the patentee. The patent was revoked for insuffciency.
Although a stay of national proceedings is the ‘default’ position in the UK, the stay was refused in this instance because of the combination of an absolute right of appeal, a minimum of two years to appeal and the potential of the ping pong effect before the EPO.